CDSCO declares 37 drug samples including Ibuprofen, Vitamin B-Complex as Not of Standard Quality Farhat Nasim30 Dec 2019 5:03 PM ISTNew Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 37 drugs including...
NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details Farhat Nasim20 Dec 2019 11:55 AM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details Medical Dialogues Bureau15 Nov 2019 4:29 PM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details Farhat Nasim16 Aug 2019 4:01 PM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details Farhat Nasim27 Jun 2019 4:07 PM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices Medical Dialogues Bureau8 Jun 2019 2:35 PM ISTAs per the CCI order, Himalaya Drug was fined Rs 18.59 crore while its three senior officials were fined a total of nearly Rs 4 lakh. Besides, Intas...
NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet Meghna A Singhania4 May 2019 12:31 PM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate Meghna A Singhania11 April 2019 10:50 AM ISTMumbai: In a move that will provide relief to cancer patients, drugmaker Intas Pharmaceuticals has recently announced the launch of Trastuzumab...
Zydus Cadila, Intas Pharma under CDSCO scanner for launching Unapproved drug Ruby Khatun Khatun10 Nov 2017 4:24 PM ISTNew Delhi: The Central Drug Standards Control Organization (CDSCO) has initiated an inquiry against the two domestic drug makers Zydus Cadila and...
Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
